SCOPUS 정보 검색 플랫폼

Volumn 186, Issue , 2015, Pages 303-304

Elevated serum soluble ST2 levels may predict the fatal outcomes in patients with chronic heart failure

(8) Yao, Heng Chen a,b Li, Xiao Yun c Han, Qian Feng b Wang, Lan Hua b Liu, Tao b Zhou, Yan Hong b Zhang, Mei a Wang, Le Xin d

a SHANDONG UNIVERSITY (China)

b TAISHAN MEDICAL UNIVERSITY (China)

c AFFILIATED HOSPITAL OF SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE (China)

d CHARLES STURT UNIVERSITY (Australia)

Author keywords

Heart failure; High sensitivity C reactive protein; N terminal pro brain natriuretic peptide; ST2

Indexed keywords

ADULT; AGE; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY SLOW FLOW PHENOMENON; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GENDER; HAMILTON DEPRESSION RATING SCALE; HUMAN; HYPERTENSION; LETTER; MALE; PRIORITY JOURNAL; SMOKING; AGED; BLOOD; CHINA; EPIDEMIOLOGY; HEART FAILURE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SURVIVAL RATE; TRENDS;

CELL SURFACE RECEPTOR; IL1RL1 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR;

AGED; CHINA; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN-1; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84929157514 PISSN: 01675273 EISSN: 18741754 Source Type: Journal
DOI: 10.1016/j.ijcard.2015.03.269 Document Type: Article

Times cited : (6)

References (12)

1
- 84875365187
- Prognostic values of serum tenascin-C in patients with ischaemic heart disease and heart failure
- H.C. Yao, Q.F. Han, A.P. Zhao, D.K. Yao, and L.X. Wang Prognostic values of serum tenascin-C in patients with ischaemic heart disease and heart failure Heart Lung Circ. 22 2013 184 187
- (2013) Heart Lung Circ. , vol.22 , pp. 184-187
- Yao, H.C.¹ Han, Q.F.² Zhao, A.P.³ Yao, D.K.⁴ Wang, L.X.⁵

2
- 27744446058
- IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
- J. Schmitz, A. Owyang, E. Oldham, Y. Song, E. Murphy, T.K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, D.M. Gorman, J.F. Bazan, and R.A. Kastelein IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 2005 479 490
- (2005) Immunity , vol.23 , pp. 479-490
- Schmitz, J.¹ Owyang, A.² Oldham, E.³ Song, Y.⁴ Murphy, E.⁵ McClanahan, T.K.⁶ Zurawski, G.⁷ Moshrefi, M.⁸ Qin, J.⁹ Li, X.¹⁰ Gorman, D.M.¹¹ Bazan, J.F.¹² Kastelein, R.A.¹³

3
- 84872600290
- Temporal changes of soluble ST2 after cardiovascular interventions
- S. Willems, J.W. Sels, S. Flier, D. Versteeg, W.F. Buhre, D.P. de Kleijn, I.E. Hoefer, and G. Pasterkamp Temporal changes of soluble ST2 after cardiovascular interventions Eur. J. Clin. Invest. 43 2013 113 120
- (2013) Eur. J. Clin. Invest. , vol.43 , pp. 113-120
- Willems, S.¹ Sels, J.W.² Flier, S.³ Versteeg, D.⁴ Buhre, W.F.⁵ De Kleijn, D.P.⁶ Hoefer, I.E.⁷ Pasterkamp, G.⁸

4
- 42149127593
- Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction
- M.S. Sabatine, D.A. Morrow, L.J. Higgins, C. MacGillivray, W. Guo, C. Bode, N. Rifai, C.P. Cannon, R.E. Gerszten, and R.T. Lee Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction Circulation 117 2008 1936 1944
- (2008) Circulation , vol.117 , pp. 1936-1944
- Sabatine, M.S.¹ Morrow, D.A.² Higgins, L.J.³ Macgillivray, C.⁴ Guo, W.⁵ Bode, C.⁶ Rifai, N.⁷ Cannon, C.P.⁸ Gerszten, R.E.⁹ Lee, R.T.¹⁰

5
- 84857609914
- Soluble ST2 is associated with adverse outcome in patients with heart failure of ischemic etiology
- K. Broch, T. Ueland, S.H. Nymo, J. Kjekshus, J. Hulthe, P. Muntendam, J.J. McMurray, J. Wikstrand, J.G. Cleland, P. Aukrust, and L. Gullestad Soluble ST2 is associated with adverse outcome in patients with heart failure of ischemic etiology Eur. J. Heart Fail. 14 2012 268 277
- (2012) Eur. J. Heart Fail. , vol.14 , pp. 268-277
- Broch, K.¹ Ueland, T.² Nymo, S.H.³ Kjekshus, J.⁴ Hulthe, J.⁵ Muntendam, P.⁶ McMurray, J.J.⁷ Wikstrand, J.⁸ Cleland, J.G.⁹ Aukrust, P.¹⁰ Gullestad, L.¹¹

6
- 81355138191
- Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction
- E. Fousteris, A. Melidonis, G. Panoutsopoulos, K. Tzirogiannis, S. Foussas, A. Theodosis-Georgilas, S. Tzerefos, S. Matsagos, E. Boutati, T. Economopoulos, G. Dimitriadis, and S. Raptis Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction Cardiovasc. Diabetol. 10 2011 101
- (2011) Cardiovasc. Diabetol. , vol.10 , pp. 101
- Fousteris, E.¹ Melidonis, A.² Panoutsopoulos, G.³ Tzirogiannis, K.⁴ Foussas, S.⁵ Theodosis-Georgilas, A.⁶ Tzerefos, S.⁷ Matsagos, S.⁸ Boutati, E.⁹ Economopoulos, T.¹⁰ Dimitriadis, G.¹¹ Raptis, S.¹²

7
- 84876673091
- Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment
- J. Lupón, M. de Antonio, A. Galán, J. Vila, E. Zamora, A. Urrutia, and A. Bayes-Genis Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment Mayo Clin. Proc. 88 2013 234 243
- (2013) Mayo Clin. Proc. , vol.88 , pp. 234-243
- Lupón, J.¹ De Antonio, M.² Galán, A.³ Vila, J.⁴ Zamora, E.⁵ Urrutia, A.⁶ Bayes-Genis, A.⁷

8
- 77949261472
- ST2: A novel remodeling biomarker in acute and chronic heart failure
- R.V. Shah, and J.L. Januzzi Jr. ST2: a novel remodeling biomarker in acute and chronic heart failure Curr. Heart Fail. Rep. 7 2010 9 14
- (2010) Curr. Heart Fail. Rep. , vol.7 , pp. 9-14
- Shah, R.V.¹ Januzzi, Jr.J.L.²

9
- 34249882513
- IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
- S. Sanada, D. Hakuno, L.J. Higgins, E.R. Schreiter, A.N. McKenzie, and R.T. Lee IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system J. Clin. Invest. 117 2007 1538 1549
- (2007) J. Clin. Invest. , vol.117 , pp. 1538-1549
- Sanada, S.¹ Hakuno, D.² Higgins, L.J.³ Schreiter, E.R.⁴ McKenzie, A.N.⁵ Lee, R.T.⁶

10
- 84929174980
- Increased serum HMGB1 level may predict the fatal outcomes in patients with chronic heart failure
- T. Liu, D.Y. Zhang, Y.H. Zhou, Q.F. Han, L.H. Wang, L. Wu, and H.C. Yao Increased serum HMGB1 level may predict the fatal outcomes in patients with chronic heart failure Int. J. Cardiol. 184 2015 318 320
- (2015) Int. J. Cardiol. , vol.184 , pp. 318-320
- Liu, T.¹ Zhang, D.Y.² Zhou, Y.H.³ Han, Q.F.⁴ Wang, L.H.⁵ Wu, L.⁶ Yao, H.C.⁷

11
- 79957454382
- Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure
- W.H. Tang, K. Shrestha, R.W. Troughton, A.G. Borowski, and A.L. Klein Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure Congest. Heart Fail. 17 2011 105 109
- (2011) Congest. Heart Fail. , vol.17 , pp. 105-109
- Tang, W.H.¹ Shrestha, K.² Troughton, R.W.³ Borowski, A.G.⁴ Klein, A.L.⁵

12
- 84878177700
- Correlation between serum high-mobility group box-1 levels and high-sensitivity C-reactive protein and troponin i in patients with coronary artery disease
- H.C. Yao, A.P. Zhao, Q.F. Han, L. Wu, D.K. Yao, and L.X. Wang Correlation between serum high-mobility group box-1 levels and high-sensitivity C-reactive protein and troponin I in patients with coronary artery disease Exp. Ther. Med. 6 2013 121 124
- (2013) Exp. Ther. Med. , vol.6 , pp. 121-124
- Yao, H.C.¹ Zhao, A.P.² Han, Q.F.³ Wu, L.⁴ Yao, D.K.⁵ Wang, L.X.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.